Salarius Pharmaceuticals, Inc.

Clinical-stage biopharma developing targeted protein therapies for cancer and viral diseases.

SLRX | NDAQ

Overview

Corporate Details

ISIN(s):: US79400X4043 (+1 more)
LEI:
Country:: United States of America
Address:: 2450 HOLCOMBE BLVD, 77021 HOUSTON
Website:: https://salariuspharma.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for patients with cancer and other diseases with high unmet medical needs. The company's technology aims to correct the dysregulated gene expression that drives disease progression. Its pipeline is built on two primary drug classes: targeted protein inhibitors (TPIs) and targeted protein degraders (TPDs). The lead TPI candidate, seclidemstat (SP-2577), is in Phase 1/2 clinical trials for solid and hematologic cancers like leukemias and lymphomas. The company's TPD candidate, SP-3164, is in IND-enabling studies. Following a merger with Decoy Therapeutics, Salarius is also advancing peptide therapeutics for cancer and respiratory viruses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Salarius Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Salarius Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Salarius Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
TRAJANO Provides strategic consulting and innovative business solutions.	Spain	YTRA
Transgene Developing viral immunotherapies like vaccines and oncolytic viruses to treat solid tumors.	France	TNG
TRANS GENIC GROUP INC. Offers drug discovery CRO services (gene editing, trials) and business investment/consulting.	Japan	2342
Trevi Therapeutics, Inc. Clinical-stage biopharma developing an oral therapy for chronic cough in IPF and RCC.	United States of America	TRVI
TrueBlue, Inc. Provides staffing, recruitment, and workforce solutions for businesses in diverse sectors.	United States of America	TBI
True Data Inc. A big data platform offering consumer purchasing analytics from Japan's largest ID-POS data network.	Japan	4416
Tsubota Laboratory Incorporated Developing pharmaceuticals and medical devices for ophthalmic and brain diseases.	Japan	4890
TWOSTONE&Sons Inc. An engineer platform providing IT talent and marketing services for corporate digital transformation.	Japan	7352
UJU Holding Limited AI-driven, full-link short-video marketing solutions for enterprises in China.	Hong Kong	1948
unerry,Inc. Transforms location data into actionable insights for retail and public sectors using AI.	Japan	5034